# Hypotaurine Supplementation Benefits in Cryopreservation

> **NCT04011813** · — · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 33 (actual)

## Conditions studied

- Cryopreservation
- Human Spermatozoa Parameters
- Hypotaurine Supplementation
- Spermatozoa DNA Alterations

## Interventions

- **OTHER:** Hypotaurine : antioxidant and osmoregulator

## Key facts

- **NCT ID:** NCT04011813
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-01
- **Primary completion:** 2018-08-01
- **Final completion:** 2019-05-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2019-07-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04011813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04011813, "Hypotaurine Supplementation Benefits in Cryopreservation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04011813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*